Cargando…

How I manage severe von Willebrand disease

Von Willebrand disease (VWD) is the most common inherited bleeding disorder. Most patients with mild and moderate VWD can be treated effectively with desmopressin. The management of severe VWD patients, mostly affected by type 2 and type 3 disease, can be challenging. In this article we review the c...

Descripción completa

Detalles Bibliográficos
Autores principales: Leebeek, Frank W. G., Atiq, Ferdows
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6899759/
https://www.ncbi.nlm.nih.gov/pubmed/31498884
http://dx.doi.org/10.1111/bjh.16186
_version_ 1783477201741545472
author Leebeek, Frank W. G.
Atiq, Ferdows
author_facet Leebeek, Frank W. G.
Atiq, Ferdows
author_sort Leebeek, Frank W. G.
collection PubMed
description Von Willebrand disease (VWD) is the most common inherited bleeding disorder. Most patients with mild and moderate VWD can be treated effectively with desmopressin. The management of severe VWD patients, mostly affected by type 2 and type 3 disease, can be challenging. In this article we review the current diagnosis and treatment of severe VWD patients. We will also discuss the management of severe VWD patients in specific situations, such as pregnancy, delivery, patients developing alloantibodies against von Willebrand factor and VWD patients with recurrent gastrointestinal bleeding. Moreover, we review emerging treatments that may be applied in future management of patients with severe VWD.
format Online
Article
Text
id pubmed-6899759
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-68997592019-12-19 How I manage severe von Willebrand disease Leebeek, Frank W. G. Atiq, Ferdows Br J Haematol Reviews Von Willebrand disease (VWD) is the most common inherited bleeding disorder. Most patients with mild and moderate VWD can be treated effectively with desmopressin. The management of severe VWD patients, mostly affected by type 2 and type 3 disease, can be challenging. In this article we review the current diagnosis and treatment of severe VWD patients. We will also discuss the management of severe VWD patients in specific situations, such as pregnancy, delivery, patients developing alloantibodies against von Willebrand factor and VWD patients with recurrent gastrointestinal bleeding. Moreover, we review emerging treatments that may be applied in future management of patients with severe VWD. John Wiley and Sons Inc. 2019-09-09 2019-11 /pmc/articles/PMC6899759/ /pubmed/31498884 http://dx.doi.org/10.1111/bjh.16186 Text en © 2019 The Authors. British Journal of Haematology published by British Society for Haematology and John Wiley & Sons Ltd This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Reviews
Leebeek, Frank W. G.
Atiq, Ferdows
How I manage severe von Willebrand disease
title How I manage severe von Willebrand disease
title_full How I manage severe von Willebrand disease
title_fullStr How I manage severe von Willebrand disease
title_full_unstemmed How I manage severe von Willebrand disease
title_short How I manage severe von Willebrand disease
title_sort how i manage severe von willebrand disease
topic Reviews
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6899759/
https://www.ncbi.nlm.nih.gov/pubmed/31498884
http://dx.doi.org/10.1111/bjh.16186
work_keys_str_mv AT leebeekfrankwg howimanageseverevonwillebranddisease
AT atiqferdows howimanageseverevonwillebranddisease